Pilot Study of a Catheter-based Ultrasound Hyperthermia System
NCT00911079 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13
Last updated 2021-07-07
Summary
RATIONALE: Hyperthermia therapy kills tumor cells by heating them to several degrees above normal body temperature. Ultrasound energy may be able to kill tumor cells by heating up the tumor cells without affecting the surrounding tissue. Implant radiation therapy uses radioactive material placed directly into or near a tumor to kill tumor cells. Giving ultrasound hyperthermia therapy after implant radiation therapy may kill more tumor cells.
PURPOSE: This clinical trial is studying ultrasound hyperthermia therapy to see how well it works after implant radiation therapy in treating patients with Stage III/IV cancer of the cervix or prostate cancer with a rising prostate specific antigen (PSA) after prior local therapy.
Conditions
Interventions
- PROCEDURE
-
Hyperthermia
Single course of Catheter-based Ultrasound Hyperthermia (within approximately 2 hours of a Standard-of-care High Dose Rate (HDR) Brachytherapy)
- RADIATION
-
HDR brachytherapy
Completion of standard-of-care high dose rate (HDR) Brachytherapy treatments (radiation fractions) using Session #1 catheter implants
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
University of California, San Francisco
lead OTHER
Principal Investigators
-
I-Chow J. Hsu, MD · University of California, San Francisco
Study Design
- Allocation
- NA
- Purpose
- DEVICE_FEASIBILITY
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-12-18
- Primary Completion
- 2020-07-23
- Completion
- 2020-07-23
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Thermal Ablation Combined With External Beam Radiation Therapy for Patients With Inoperable Non-Small Cell Lung Cancer > 3.5 cm in Size
NCT01028612 ·Status: TERMINATED ·Phase: NA
-
Study of High-Intensity Focused Ultrasound (HIFU) Combined With Toripalimab Plus Chemotherapy Versus Chemotherapy as Neoadjuvant Therapy for Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (NeoHunter)
NCT06964906 ·Status: RECRUITING ·Phase: PHASE2
-
Hyperthermia Enhanced Re-irradiation of Loco-regional Recurrent Tumors
NCT04889742 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
3-D Super Resolution Ultrasound Microvascular Imaging
NCT04136912 ·Status: TERMINATED ·Phase: PHASE2
-
Proton Beam Teletherapy for Post-Hysterectomy Cancers of the Uterus and Cervix
NCT01600040 ·Status: COMPLETED ·Phase: NA
-
Prophylactic Irradiation of the Para-Aortic Lymph Nodes in Locally Advanced Uterine Cervical Cancer
NCT00980759 ·Status: UNKNOWN ·Phase: NA
-
A Study of Patients Receiving High-Dose Rate Brachytherapy
NCT00924027 ·Status: COMPLETED ·Phase: PHASE2
-
High Dose Intensity Modulated Radiation Therapy in the Cervical Cancer With Metastatic Lymphadenopathies.
NCT01730651 ·Status: UNKNOWN ·Phase: NA
-
2D vs 3D Planning for High-Dose Rate (HDR) Gynecological Brachytherapy
NCT02091050 ·Status: COMPLETED ·Phase: PHASE2
-
Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas
NCT03989596 ·Status: UNKNOWN ·Phase: PHASE2
-
RF Ablation of Treatment of Metastatic Lesions in Patients Undergoing Antiangiogenic Therapy for Stage IV Renal Cell Carcinoma
NCT00601120 ·Status: WITHDRAWN ·Phase: NA
-
Dose Escalation of Hypofractionated Radiation Therapy in Patients With Metastatic Cancer
NCT01215500 ·Status: COMPLETED ·Phase: PHASE1
-
Radiotherapy With Hyperthermia in Recurrent and Radiation-Induced Sarcomas
NCT04398095 ·Status: COMPLETED ·Phase: NA
-
Intraductal Radiofrequency Thermoablation and Radiotherapy Combined Treatment for Extrahepatic Cholangiocarcinoma
NCT06168292 ·Status: RECRUITING ·Phase: NA
-
Carotid Ultrasound to Identify Head and Neck Cancer Survivors With High Cardiovascular Risk After Radiation Therapy
NCT05490875 ·Status: COMPLETED
-
The HIFUB Study (HIFU in Breast Cancer)
NCT05350059 ·Status: UNKNOWN ·Phase: NA
-
Hyperthermia Combined With Immunotherapy in the Treatment of Abdominal and Pelvic Malignancies or Metastases
NCT03757858 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Adaptive, Image-guided, Intensity-modulated Radiotherapy for Head and Neck Cancer in the Reduced Volumes of Elective Neck
NCT01287390 ·Status: COMPLETED ·Phase: PHASE2
-
Cryosurgery and Radiation Therapy in Treating Patients With Painful Bone Metastases
NCT01767935 ·Status: TERMINATED ·Phase: NA
-
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
NCT02701153 ·Status: RECRUITING ·Phase: NA
-
Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Uterine Cancer
NCT01367301 ·Status: TERMINATED ·Phase: NA
-
A Study For Using Radiosurgery On Limited Metastases
NCT00178399 ·Status: COMPLETED ·Phase: NA
-
Grid Therapy for Tumors of the Head, Neck, Thorax, Abdomen, Pelvis and Extremities.
NCT04549246 ·Status: COMPLETED
-
Preoperative 5-Day Radiotherapy for Soft Tissue Sarcoma
NCT06905132 ·Status: RECRUITING ·Phase: PHASE2
-
Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer
NCT01896778 ·Status: COMPLETED ·Phase: NA